P44 Multiple Myeloma Total Direct Costs in Colombia: A National Cohort Study Based on Administrative Claims Databases

Abstract

Multiple myeloma (MM) is associated with a substantial economic burden for health systems worldwide, however, evidence regarding this burden in middle-income countries is lacking. Colombia, a middle-income country, provides healthcare services included and not included in its Health Benefit Package (HBP and non-HBP services, respectively) to its population through several insurance regimes. Almost 48% of Colombian population receive healthcare services through the contributory regime. This study aims to describe the costs of healthcare services delivered to patients with MM affiliated with the contributory regime in 2018.